An improvement in lipid profile was also observed in both formulations, with significant reduction in LDL
These actions occur continuously once therapeutic levels are established, regardless of when the injection is administered
The FDA did approve sermorelin acetate for the first time in 1997 under the brand name GEREF [10]
Tsimberidou AM, Keating MJ, Giles FJ, Wierda WG, Ferrajoli A, Lerner S, Beran M, Andreeff M , Kantarjian HM, O'Brien S
Reusing needles or syringes introduces contamination from previous use
Most compounding pharmacies recommend continuous refrigeration and limit room temperature exposure to 24 to 72 hours depending on the formulation